Mission Viejo, CA Mon–Fri 9–5 · Sat 9–1 Free consultation available — Book today
Glass vial and fine syringe on a sterile tray — botox vs jeuveau (‘newtox’) at OC Weight Loss & Med Spa, Mission Viejo
Photo: Tara Winstead / Pexels

Botox vs Jeuveau (‘Newtox’): Cost, Onset, Results Compared (2026)

Medically reviewed by the clinical team at OC Weight Loss & Med Spa · Last reviewed

If you have looked into a neurotoxin treatment lately, you have probably heard of Jeuveau, sometimes nicknamed the “Newtox.” It shows up in price lists right next to Botox, often a few dollars cheaper per unit, and patients naturally ask whether the two are basically the same thing.

The short answer is that they are close cousins, not twins. Both are made from the same purified protein and both smooth wrinkles by relaxing the muscles underneath. But there are real differences in how each one is approved, how fast it kicks in, and what it tends to cost.

Below we break down Botox vs Jeuveau the way we would explain it across the table during a consultation in Mission Viejo, so you can decide which one fits your face, your timeline, and your budget.

Here is the gist: Botox (onabotulinumtoxinA) and Jeuveau (prabotulinumtoxinA) share the same active botulinum toxin type A protein and work the same way. Jeuveau is FDA-approved for cosmetic use only, while Botox carries both cosmetic and many medical approvals. Jeuveau may start working slightly faster (often 2–3 days), both last roughly 3–4 months, and Jeuveau is frequently priced a little lower per unit. For frown lines and crow’s feet, both deliver comparable results, so the choice usually comes down to cost, your injector’s experience, and personal preference.

What is Jeuveau (the “Newtox”)?

Jeuveau is a botulinum toxin type A injectable made by Evolus and FDA-approved in 2019 specifically to soften moderate-to-severe frown lines between the brows. Its generic name is prabotulinumtoxinA-xvfs. The “Newtox” nickname stuck because it was the first new cosmetic-only neurotoxin to reach the U.S. market in years.

The word “cosmetic-only” matters. Unlike Botox, Jeuveau is not approved to treat medical conditions like chronic migraine, excessive sweating, or muscle spasticity. It was designed and studied for aesthetics from the start, which keeps its lane narrow but well-defined.

If you want the full landscape of injectables we offer, our neurotoxins guide walks through every option side by side.

How are Botox and Jeuveau similar?

Both are purified botulinum toxin type A, and both work by temporarily blocking the nerve signal that tells a muscle to contract. When the muscle relaxes, the overlying skin stops creasing, so the dynamic wrinkles that form when you frown or squint soften.

  • Same active protein family: botulinum toxin type A in both products.
  • Same core mechanism: they block acetylcholine release at the nerve-muscle junction, easing muscle pull.
  • Same primary targets: frown lines (the “11s”), forehead lines, and crow’s feet respond well to either.
  • Similar dosing concept: both are measured in units, and units are not interchangeable between brands one-for-one but track closely.
  • Similar downtime: essentially none—most people return to normal activity the same day.

Botox vs Jeuveau at a glance

FactorBotoxJeuveau ("Newtox")
What it isonabotulinumtoxinA — botulinum toxin type AprabotulinumtoxinA — the same botulinum toxin type A protein
FDA approval scopeBoth cosmetic and many medical approvalsFDA-approved for cosmetic use only
OnsetOften takes 3–5 days to begin; full results around 10–14 daysSome patients notice it in 2–3 days; full results around 10–14 days
How long it lastsTypically about 3–4 months for cosmetic useTypically about 3–4 months for cosmetic use
Cost basisFrequently the higher per-unit price; final cost depends on units usedFrequently a little lower per unit; not always a lower total bill
DowntimeEssentially none; most return to normal activity the same dayEssentially none; most return to normal activity the same day

How are Botox and Jeuveau different?

The biggest difference is scope of approval. Botox holds a long list of FDA approvals for both cosmetic and medical uses, while Jeuveau is cleared only for glabellar (frown) lines as a cosmetic treatment. A few other practical differences show up in the chair.

  • Approval scope: Botox treats wrinkles plus medical conditions; Jeuveau is cosmetic-only.
  • Onset: some patients notice Jeuveau working in 2–3 days, while Botox often takes 3–5 days to begin; full results for both land around 10–14 days.
  • Formulation details: the proteins are manufactured by different companies with proprietary processes, which can subtly affect how each spreads.
  • Price: Jeuveau is frequently priced slightly lower per unit, though final cost depends on units used.
  • Loyalty programs: Botox uses Allergan’s rewards program, Jeuveau uses Evolus Rewards—worth checking if you treat regularly.

Botox vs Jeuveau: side-by-side comparison

Here is a quick reference table comparing the two on the points patients ask about most. Individual results vary, so treat these as general ranges rather than guarantees.

Onset: which one works faster?

Onset is where Jeuveau gets some of its buzz. In practice, a number of patients report seeing Jeuveau begin to take effect around 2–3 days after treatment, while Botox more commonly starts to show in 3–5 days. For both, the full result lands around 10–14 days, so the difference is mostly about the first signs, not the finished look.

Does a day or two of head start matter? For most cosmetic patients, not much—you are planning around the two-week full-result mark either way. But if you have an event next weekend and want movement to soften as early as possible, the faster early onset can be a small point in Jeuveau’s favor. Just do not expect a dramatic difference.

It is also worth knowing that onset varies person to person. How your body metabolizes the toxin, the dose used, and the muscle treated all play a role. Two people can get the same product and notice it at slightly different times.

Longevity: how long does each one last?

Both Botox and Jeuveau typically last about 3–4 months for cosmetic use. As the neurotoxin wears off, the treated muscle slowly regains its strength and the wrinkles gradually return. There is no abrupt cutoff—it is a gentle fade back to baseline.

Several factors influence how long your results hold, regardless of which product you choose:

  • Dose: too few units may wear off sooner; an adequate dose tends to last the full window.
  • Muscle strength: strong, active muscles (common in younger patients or heavy expressers) can metabolize the product faster.
  • Metabolism and activity: very active people sometimes find results fade a touch sooner.
  • Treatment area: small, constantly moving areas wear off faster than larger, less mobile ones.
  • Consistency: regular treatment over time can train muscles to weaken, sometimes stretching the interval between visits.

Cost: is Jeuveau really cheaper?

Jeuveau is frequently priced a little lower per unit than Botox, which is part of its appeal as the “Newtox.” But per-unit price is only half the math. What actually matters is your total cost, which is per-unit price multiplied by the number of units you need.

Because units are not perfectly interchangeable between brands, the unit count for the same result can differ slightly. So a lower sticker price per unit does not always mean a lower bill. The honest way to compare is to ask your injector for a full quote on each option based on your treatment plan, then compare the totals.

Both brands also run loyalty programs that can offset cost over time—Allergan’s rewards for Botox and Evolus Rewards for Jeuveau. If you treat a few times a year, those points add up and may sway the value calculation.

Are Botox and Jeuveau safe?

Both are FDA-approved and have well-established safety profiles when administered by a trained, licensed injector. Botulinum toxin type A has a long history of cosmetic use, and Jeuveau cleared the FDA’s review process for frown lines in 2019.

Common side effects for either product are mild and temporary—think small bruises, slight swelling, or a brief headache at the injection sites. More significant issues like an eyelid or brow droop are uncommon and usually trace back to injection technique or product spreading, which is why injector experience matters more than the brand you pick.

As with any medical treatment, certain people should avoid neurotoxins, including those who are pregnant or breastfeeding or who have specific neuromuscular conditions. A consultation is where we screen for all of that.

What to expect during and after treatment

Whichever product you choose, the visit looks the same. After a brief assessment of your muscle movement, your injector marks the points, cleans the skin, and uses a very fine needle to place the product. The whole thing usually takes 10–15 minutes, and most people describe it as a series of quick pinches.

Aftercare is simple but worth following:

  • Stay upright for about four hours after treatment.
  • Skip strenuous exercise, saunas, and heavy alcohol the rest of the day.
  • Avoid rubbing or massaging the treated areas so the product stays where it was placed.
  • Expect to see early changes within a few days and the full result in about two weeks.

There is no real downtime with either Botox or Jeuveau. Most people head straight back to work or errands, which is part of why neurotoxins remain the most popular cosmetic treatment in the country.

Which one should you choose?

For most people seeking smoother frown lines or crow’s feet, either product works well, so the decision often comes down to cost and your injector’s comfort with each. If you also want to treat a medical issue like migraines or sweating, Botox is the one with those approvals.

A few rules of thumb we use:

  • Choose Jeuveau if you want a cosmetic-only option, like the slightly faster onset, and want to keep per-unit cost down.
  • Choose Botox if you have a medical indication, prefer the brand with the longest track record, or have responded well to it before.
  • If you have used one and were happy, there is rarely a strong reason to switch—consistency with a product and injector matters.

Curious how these stack up against other neurotoxins? Compare Botox vs Dysport for spread and onset, or Botox vs Daxxify for the longer-lasting option.

How Botox and Jeuveau fit into the wider neurotoxin family

Botox and Jeuveau are two members of a growing family of botulinum toxin type A products available in the U.S. Knowing the others helps put the comparison in context, because the right choice for you may not be either of these two.

The main players you will hear about include:

  • Botox (onabotulinumtoxinA): the original and most widely used, with both cosmetic and medical approvals.
  • Jeuveau (prabotulinumtoxinA): the cosmetic-only “Newtox,” often priced slightly lower.
  • Dysport (abobotulinumtoxinA): known for spreading a bit more, which some injectors prefer for larger areas like the forehead.
  • Xeomin (incobotulinumtoxinA): a “naked” toxin without surrounding proteins, sometimes chosen for patients who have stopped responding to others.
  • Daxxify (daxibotulinumtoxinA): the newer option marketed for potentially longer-lasting results.

All of these work on the same basic principle—relaxing targeted muscles to soften dynamic wrinkles. They differ in spread, onset, longevity, and price. An experienced injector will often carry several and match the product to your anatomy and goals rather than pushing a single brand.

Common myths about Jeuveau

Because Jeuveau is newer, it attracts a few misconceptions. Clearing these up helps you make a level-headed choice.

  • Myth: Jeuveau is a generic Botox. It is its own FDA-approved product with a different manufacturer and formulation, not a generic.
  • Myth: cheaper means weaker. A lower per-unit price reflects market positioning, not reduced effectiveness—clinical results are comparable for frown lines.
  • Myth: it does not last as long. Longevity is similar to Botox, roughly 3–4 months for most people.
  • Myth: it is experimental. Jeuveau has been FDA-approved and on the U.S. market since 2019 with an established safety record.

FAQ

Is Jeuveau just a cheaper Botox?

Not exactly. Jeuveau is a separate FDA-approved product with its own manufacturer and proprietary formulation. It is often priced a little lower per unit, but it is its own neurotoxin, not a generic version of Botox.

Does Jeuveau last as long as Botox?

In practice, yes. Both typically last about 3–4 months for cosmetic use, though longevity varies by person, dose, and treatment area. Some patients find one lasts marginally longer for them, but the average is similar.

Can I switch from Botox to Jeuveau?

Yes. Many patients move between neurotoxins without issue. Your injector will adjust units as needed since brands are not dosed one-for-one. Tell your provider what you used before so they can plan accordingly.

Does Jeuveau work faster than Botox?

It can. Some patients report seeing Jeuveau take effect in about 2–3 days, while Botox often starts around 3–5 days. Both reach full results in roughly 10–14 days, so the early-onset edge is modest.

Is Jeuveau FDA-approved?

Yes. The FDA approved Jeuveau in 2019 for moderate-to-severe glabellar (frown) lines. It is approved for cosmetic use only and not for medical conditions like migraine or hyperhidrosis.

Which is better for crow’s feet?

Both can soften crow’s feet effectively. Note that crow’s feet are an off-label area for both products since each is FDA-approved specifically for frown lines, but experienced injectors treat them routinely with good results.

Book a neurotoxin consultation in Mission Viejo

The best way to pick between Botox and Jeuveau is a quick face-to-face assessment of your muscle strength, anatomy, and goals. Our injectors will recommend the product and dose that fit you, and explain the cost before anything happens.

Explore our Botox & neurotoxin services

Related treatments at our Mission Viejo clinic

Not sure which treatment fits? These are the related services our clinicians most often discuss at a consultation.

References

  1. Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials — Aesthetic Plast Surg 2023, via PubMed
  2. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials — Plast Reconstr Surg 2015, via PubMed
  3. Efficacy and safety of Botulinum toxin A for improving esthetics in facial complex: A systematic review — Braz Dent J 2021, via PubMed
Book a Free Consultation